Trial intelligence / Profile preview

Nano-COVID19: MTX-LDE in COVID-19

NCT04610567Phase 2Unknown

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Oct 2020
Primary completion
Mar 2021
Countries
1
01

Overview

A Phase 2 trial of methotrexate-LDE in coronavirus disease 2019 (COVID-19), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Status: unknown.

02

Drugs

methotrexate-LDE
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04610567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04610567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call